A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Abatacept
Related studies linked through entity extraction aliases.
Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes
- Status
- COMPLETED
- Phase
- PHASE1
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Abatacept in IgG4-Related Disease
- Status
- COMPLETED
- Phase
- PHASE2
Rheumatoid Arthritis Memory B Cells and Abatacept
- Status
- COMPLETED
- Phase
- PHASE4
Abatacept in earLy Onset Polymyalgia Rheumatica: Study ALORS
- Status
- UNKNOWN
- Phase
- PHASE3
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE4
Abatacept to Silence Anti-citrullinated Protein Antibody-expressing B Cells in Rheumatoid Arthritis (ASCARA)
- Status
- COMPLETED
- Phase
- PHASE4
Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients
- Status
- UNKNOWN
- Phase
- N/A
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
- Status
- RECRUITING
- Phase
- PHASE3
Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA)
- Status
- WITHDRAWN
- Phase
- PHASE3
A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDs
- Status
- COMPLETED
- Phase
- PHASE3
APRIL (AbatacePt in Rheumatoid Arthritis-ILD)
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Tapering in JIA With Inactive Disease
- Status
- COMPLETED
- Phase
- PHASE3
Pharmacokinetics, Safety and Tolerability Study of Single Dose of Abatacept 125mg Administered Subcutaneously
- Status
- UNKNOWN
- Phase
- PHASE1